<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">57679</article-id><article-id pub-id-type="doi">10.7554/eLife.57679</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group></article-categories><title-group><article-title>The testis protein ZNF165 is a SMAD3 cofactor that coordinates oncogenic TGFβ signaling in triple-negative breast cancer</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-149326"><name><surname>Gibbs</surname><given-names>Zane A</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0294-1878</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-149327"><name><surname>Reza</surname><given-names>Luis</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-183179"><name><surname>Cheng</surname><given-names>Chun-chun</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-183180"><name><surname>Westcott</surname><given-names>Jill</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-149328"><name><surname>McGlynn</surname><given-names>Kathleen</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-149038"><name><surname>Whitehurst</surname><given-names>Angelique</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9505-0240</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Pharmacology</institution>, <institution>University of Texas Southwestern Medical Center</institution>, <addr-line><named-content content-type="city">Dallas</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Hamon Center for Therapeutic Oncology Research</institution>, <institution>University of Texas Southwestern Medical Center</institution>, <addr-line><named-content content-type="city">Dallas</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1082"><name><surname>Espinosa</surname><given-names>Joaquín M</given-names></name><role>Reviewing editor</role><aff><institution>University of Colorado Anschutz Medical Campus</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>angelique.whitehurst@utsouthwestern.edu</email> (AW);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>09</day><month>06</month><year>2020</year></pub-date><volume>9</volume><elocation-id>e57679</elocation-id><history><date date-type="received"><day>08</day><month>04</month><year>2020</year></date><date date-type="accepted"><day>09</day><month>06</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Gibbs et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Gibbs et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-57679-v1.pdf"/><abstract><p>Cancer/testis (CT) antigens are proteins whose expression is normally restricted to germ cells yet aberrantly activated in tumors, where their functions remain relatively cryptic. Here we report that ZNF165, a CT antigen frequently expressed in triple-negative breast cancer (TNBC), associates with SMAD3 to modulate transcription of transforming growth factor β (TGFβ)-dependent genes and thereby promote growth and survival of human TNBC cells. In addition, we identify the KRAB zinc finger protein, ZNF446, and its associated tripartite motif protein, TRIM27, as obligate components of the ZNF165-SMAD3 complex that also support tumor cell viability. Importantly, we find that TRIM27 alone is necessary for ZNF165 transcriptional activity and is required for TNBC tumor growth <italic>in vivo </italic>using an orthotopic xenograft model in immunocompromised mice. Our findings indicate that aberrant expression of a testis-specific transcription factor is sufficient to co-opt somatic transcriptional machinery to drive a pro-tumorigenic gene expression program in TNBC.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>5R01CA196905</award-id><principal-award-recipient><name><surname>Gibbs</surname><given-names>Zane A</given-names></name><name><surname>Reza</surname><given-names>Luis</given-names></name><name><surname>Cheng</surname><given-names>Chun-chun</given-names></name><name><surname>Whitehurst</surname><given-names>Angelique</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>5T32GM007062</award-id><principal-award-recipient><name><surname>Gibbs</surname><given-names>Zane A</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (2016-101795) of UT-Southwestern. All surgery was performed under anesthesia, and every effort was made to minimize suffering.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Data have been submitted under GEO access code GSE130364.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Gibbs Z</collab><collab>Whitehurst AW</collab></person-group><year iso-8601-date="2020">2020</year><source>Genomic binding profiles for ZNF165, ZNF446, and SMAD3 in triple-negative breast cancer</source><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE130364">http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE130364</ext-link><comment>NCBI Gene Expression Omnibus, GSE130364</comment></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation id="dataset2" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Whitehurst A</collab><collab>Maxfield K</collab></person-group><year iso-8601-date="2015">2015</year><source>ChIP-Seq analysis to identify direct binding of ZNF165</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE65937">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE65937</ext-link><comment>NCBI Gene Expression Omnibus, GSE65937</comment></element-citation><element-citation id="dataset3" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Tufegdzic Vidakovic A</collab><collab>Rueda OM</collab><collab>Vervoort SJ</collab><collab>Sati Batra A</collab><collab>Goldgraben MA</collab><collab>Uribe-Lewis S</collab><collab>Greenwood W</collab><collab>Coffer PJ</collab><collab>Bruna A</collab><collab>Caldas C</collab></person-group><year iso-8601-date="2015">2015</year><source>Context-Specific Effects of TGF-β/SMAD3 in Cancer Are Modulated by the Epigenome.</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/ega/studies/EGAS00001001570">https://www.ebi.ac.uk/ega/studies/EGAS00001001570</ext-link><comment>EBI, EGAS00001001570</comment></element-citation><element-citation id="dataset4" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Whitehurst A</collab><collab>Maxfield K</collab></person-group><year iso-8601-date="2015">2015</year><source>Integrative Functional Characterization of Cancer-Testis Antigens Defines Obligate Participation in Multiple Hallmarks of Cancer</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi</ext-link><comment>NCBI Gene Expression Omnibus, GSE63986</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-57679-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>